• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vineet Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 71715.0
  • ISIN : INE505Y01010
34.16 2 (4.82%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    32.05

  • Today’s High

    34.21

  • Open

    34.21

  • Perv Close

    32.59

  • 52W Low

    26.51

  • 52W High

    70.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    31.49

  • Div & Yield %

    0.00

  • Book Value(₹)

    14.99

  • Debt-Equity Ratio

    4.82

  • AGM Date

    01-Aug-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    31.49

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    9.22

  • BV (₹)

    15.00

  • Sales( ₹ in Cr.)

    75.00

  • NP (in Cr.)

    -20.19

  • NP Var(%)

    -2663.0

  • Div%

    0.0

  • CPS (₹)

    -19.20

  • EPS (₹)

    -21.90

  • Traded Value (₹ in Lakhs)

    30.61

  • 52 Week High

    70.00

  • 52 Week Low

    26.51

  • Price BSE

    33.0

  • Price NSE

    34.00

  • Market Capital( in Cr.)

    30.61

  • P/C Ratio

    -1.70

  • P/E Ratio

    -1.50

  • Price Vs.BV

    -21.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 150.59 212.29 191.17 243.48 0.00 -
Excise Duty 0.00 0.00 0.00 0.00 0.00 -
Net Sales 150.59 212.29 191.17 243.48 0.00 -
Other Income 0.46 0.12 0.29 0.39 0.00 -
Stock Adjustments 17.79 -4.23 5.85 -5.36 0.00 -
Total Income 168.84 208.18 197.31 238.51 0.00 -
EXPENDITURE :            
Raw Materials 131.70 168.10 151.40 192.76 0.00 -
Power and Fuel Cost 6.30 6.15 4.74 7.03 0.00 -
Employee Cost 6.38 6.00 4.91 5.57 0.00 -
Other Manufacturing Expenses 11.63 13.40 16.94 21.20 0.00 -
Selling and Administration Expenses 5.10 5.58 5.09 2.42 0.01 -
Miscellaneous Expenses 0.06 1.18 0.79 1.00 0.00 -
Employee Benefit Expenses 6.38 6.00 4.91 5.57 0.00 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 161.17 200.41 183.86 229.98 0.01 -
Operating Profit 7.66 7.78 13.45 8.54 -0.01 -
Interest 4.78 3.38 2.09 2.67 0.00 -
Gross Profit 2.88 4.40 11.36 5.87 -0.01 -
Depreciation 2.52 2.37 2.02 1.81 0.00 -
Profit Before Tax 0.36 2.03 9.34 4.06 -0.01 -
Current Tax -0.06 0.56 3.18 1.28 0.00 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax -0.60 0.22 -0.48 1.00 0.00 -
Reported Net Profit 1.03 1.25 6.64 1.78 -0.01 -
Extraordinary Items 0.24 0.00 0.00 0.00 0.00 -
Adjusted Net Profit 0.79 1.25 6.64 1.78 -0.01 -
Adjustment below Net Profit 0.00 0.00 -0.04 0.22 0.00 -
P & L Balance brought forward 13.24 12.91 6.31 4.31 0.00 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 0.00 0.92 0.00 0.00 0.00 -
P & L Balance carried down 14.27 13.24 12.91 6.31 -0.01 -
Dividend 0.00 0.00 0.00 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 0.00 0.00 10.00 0.00 0.00 -
Dividend Per Share(Rs) 0.00 0.00 1.00 0.00 0.00 -
Earnings Per Share-Unit Curr 1.11 1.36 7.20 1.93 -0.27 -
Earnings Per Share(Adj)-Unit Curr 1.11 1.36 7.20 - - -
Book Value 37.67 36.54 36.03 28.87 9.73 -
Book Value(Adj)-Unit Curr 37.67 36.54 36.03 - - -

Shareholding Pattern

  • Promoter Group

    29.26%

  • Public Share Holding

    70.74%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,697,444 29.26 2,697,444 14
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,697,444 29.26 2,697,444 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 250,841 2.72 250,841 33
Clearing Members 2,072 0.02 2,072 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 96,406 1.05 96,406 61
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,219,092 24.07 2,219,092 30
Individuals holding nominal share capital up to Rs. 1 lakh 3,953,153 42.88 3,953,153 9,848
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,521,564 70.74 6,521,564 9,974
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 9,219,008 100.00 9,219,008 9,988

Company Background

Vineet Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Vineet Laboratories Ltd
  • BSE Code : 71715.0
  • ISIN : INE505Y01010

  • Incorporation Year

    2016

  • Registered Office

    SyNo 11/A3 Saheb Nagar KurduVi
    Chintal Kunta Eshwaramma LB Nr, Hyderabad,
    Telangana-500074

  • Telephone

    91-40-24128833

  • FAX

  • Chairman

    Dilip V Acharekar

  • Managing Director

    Gaddam Venkata Ramana

  • Company Secretary

    Rameshkumar Bandari

  • Auditor

    NSVR & Associates LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Vineet Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vineet Laborator 33.20 151.05 150.59 -1.62 6.59
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10